Paravasthu Mukund - Oct 1, 2024 Form 3 Insider Report for NovoCure Ltd (NVCR)

Role
Chief Operating Officer
Signature
Steven Robbins, as attorney in fact for Paravasthu, Mukund
Stock symbol
NVCR
Transactions as of
Oct 1, 2024
Transactions value $
$0
Form type
3
Date filed
10/9/2024, 06:21 PM

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding NVCR Ordinary Shares 3.66K Oct 1, 2024 Direct
holding NVCR Restricted Share Units 154 Oct 1, 2024 Direct F1
holding NVCR Restricted Share Units 826 Oct 1, 2024 Direct F2
holding NVCR Restricted Share Units 1.99K Oct 1, 2024 Direct F3
holding NVCR Restricted Share Units 1.14K Oct 1, 2024 Direct F4
holding NVCR Restricted Share Units 2.38K Oct 1, 2024 Direct F5
holding NVCR Restricted Share Units 18.5K Oct 1, 2024 Direct F6
holding NVCR Restricted Share Units 15.3K Oct 1, 2024 Direct F7

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding NVCR Stock Options (Right to buy) Oct 1, 2024 Ordinary Shares 3.85K $153.09 Direct F8
holding NVCR Stock Options (Right to buy) Oct 1, 2024 Ordinary Shares 653 $153.09 Direct F9
holding NVCR Stock Options (Right to buy) Oct 1, 2024 Ordinary Shares 831 $107.73 Direct F10
holding NVCR Stock Options (Right to buy) Oct 1, 2024 Ordinary Shares 10.1K $83.77 Direct F11
holding NVCR Stock Options (Right to buy) Oct 1, 2024 Ordinary Shares 148 $83.77 Direct F12
holding NVCR Stock Options (Right to buy) Oct 1, 2024 Ordinary Shares 3.26K $80.59 Direct F13
holding NVCR Stock Options (Right to buy) Oct 1, 2024 Ordinary Shares 1.09K $80.59 Direct F14
holding NVCR Stock Options (Right to buy) Oct 1, 2024 Ordinary Shares 4.64K $76.97 Direct F15
holding NVCR Stock Options (Right to buy) Oct 1, 2024 Ordinary Shares 1.3K $76.97 Direct F16
holding NVCR Stock Options (Right to buy) Oct 1, 2024 Ordinary Shares 2.9K $73.20 Direct F17
holding NVCR Stock Options (Right to buy) Oct 1, 2024 Ordinary Shares 4.67K $64.15 Direct F18
holding NVCR Stock Options (Right to buy) Oct 1, 2024 Ordinary Shares 5.42K $64.15 Direct F18
holding NVCR Stock Options (Right to buy) Oct 1, 2024 Ordinary Shares 23.3K $16.30 Direct F19
holding NVCR Stock Options (Right to buy) Oct 1, 2024 Ordinary Shares 201 $16.30 Direct F20
holding NVCR Stock Options (Right to buy) Oct 1, 2024 Ordinary Shares 7.15K $13.54 Direct F21
holding NVCR Stock Options (Right to buy) Oct 1, 2024 Ordinary Shares 21.4K $13.54 Direct F22
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted share units that are scheduled to vest on November 2, 2024, subject to the reporting person's continued employment through such date.
F10 Options to buy 831 ordinary shares, 416 shares of which are currently exercisable and the remainder will vest in equal installments on each of November 2, 2024 and 2025, subject to the reporting person's continued employment through such dates.
F11 Options to buy 10,109 ordinary shares, 5,129 shares of which are currently exercisable and the remainder will vest in equal installments on each of May 3, 2025 and 2026, subject to the reporting person's continued employment through such dates.
F12 These stock options will vest on May 3, 2026, subject to the reporting person's continued employment through such date.
F13 Options to buy 3,260 ordinary shares, 2,174 shares of which are currently exercisable and the remainder will vest on March 1, 2025, subject to the reporting person's continued employment through such date.
F14 Options to buy 1,086 ordinary shares will vest on March 1, 2026, subject to the reporting person's continued employment through such date.
F15 Options to buy 4,644 ordinary shares, 1,486 shares of which are currently exercisable and the remainder will vest in equal installments on each of February 28, 2025, 2026 and 2027, subject to the reporting person's continued employment through such dates.
F16 These stock options will vest on February 28, 2027, subject to the reporting person's continued employment through such date.
F17 Options to buy 2,902 ordinary shares, 726 shares of which are currently exercisable and the remainder will vest in equal installments on each of November 1, 2024, 2025 and 2026, subject to the reporting person's continued employment through such dates.
F18 Currently exercisable.
F19 Options to buy 23,251 ordinary shares will vest in equal installments on each of February 27, 2025, 2026, 2027 and 2028, subject to the reporting person's continued employment through such dates.
F2 Represents restricted share units that are scheduled to vest on March 1, 2025, subject to the reporting person's continued employment through such date.
F20 These stock options will vest on February 27, 2028, subject to the reporting person's continued employment through such date.
F21 Options to buy 7,146 ordinary shares, 2 shares will vest on January 11, 2025, 1 share will vest on January 11, 2027 and the remaining shares will vest on January 11, 2028, subject to the reporting person's continued employment through such dates.
F22 Options to buy 21,426 ordinary shares will vest in equal installments on each of January 11, 2025, 2026 and 2027, subject to the reporting person's continued employment through such dates.
F3 Represents restricted share units that are scheduled to vest on May 3, 2025, subject to the reporting person's continued employment through such date.
F4 Represents restricted share units that are scheduled to vest in equal installments on November 1, 2024 and 2025, subject to the reporting person's continued employment through such dates.
F5 Represents restricted share units that are scheduled to vest in equal installments on February 28, 2025 and 2026, subject to the reporting person's continued employment through such dates.
F6 Represents restricted share units that are scheduled to vest in equal installments on January 11, 2025, 2026 and 2027, subject to the reporting person's continued employment through such dates.
F7 Represents restricted share units that are scheduled to vest in equal installments on February 27, 2025, 2026 and 2027, subject to the reporting person's continued employment through such dates.
F8 Options to buy 3,848 ordinary shares, 3,376 shares of which are currently exercisable and the remainder will vest on March 2, 2025, subject to the reporting person's continued employment through such date.
F9 These stock options will vest on March 2, 2025, subject to the reporting person's continued employment through such date.